Kojiro Tashiro

Incidence of bone fracture in patients receiving luteinizing hormone‐releasing hormone agonists for prostate cancer

Takashi Hatano, Yukihiko Oishi, Akira Furuta et al. · British Journal of Urology · 2000 · 153 citations

Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis

Ashutosh Tiwari, Kojiro Tashiro, Ajay Dixit et al. · Gastroenterology · 2020 · 140 citations · Full text

Tumor Biology, Pancreatic Cancer, Medicine +7

Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR

Takashi Kobayashi, Katsuhiro Ito, Takahiro Kojima et al. · Cancer Immunology Immunotherapy · 2021 · 37 citations · Full text

Urology, Second-line Pembrolizumab Treatment, Genitourinary Cancer +7

Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events

Michie Katsuta, TAKAHIRO KIMURA, Kojiro Tashiro et al. · Anticancer Research · 2022 · 25 citations

Prostate cancer and liquid biopsies: Clinical applications and challenges

Fumihiko Urabe, Takayuki Sumiyoshi, Kojiro Tashiro et al. · International Journal of Urology · 2024 · 22 citations · Full text